FDA NDC Directory · JSON-LD · Markdown

AMJEVITA

NDC 55513-482 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameadalimumab-atto
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA761024
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsADALIMUMAB (40 mg/.4mL)
Marketing started20230814
Package count2

External sources

Source: openFDA. Public-domain (CC0).